Biotech

All Articles

Former Seagen CEO reveals brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2015 for an enormous $4...

Ironwood creates additional purpose $1B GI drug along with new subgroup records

.On the heels of a phase 3 win that neglected to blow away entrepreneurs, Ironwood Pharmaceuticals i...

Novartis inks $150M offer for autoimmune molecular adhesive

.Do not quit Monte Rosa Therapies currently. The Boston-based biotech is actually having a ball afte...

Jade takes director staff along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, firings and...

Septerna goes public with upsized offering of $288M

.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie creates Richter wealthier, paying for $25M to form breakthrough treaty

.AbbVie has actually gone back to the source of its own antipsychotic powerhouse Vraylar in search o...

GenSight enters final full weeks of cash runway as income flow squeezes by of scope

.GenSight Biologics is actually weeks off of lacking amount of money. Once again. The biotech merely...

AZ licenses thrown out uncommon condition medicine to Monopar Therapies

.Monopar Therapies is recuperating a medication coming from the dump of AstraZeneca's rare illness p...

Arcus' brand new HIF-2a information in renal cancer cells hint at prospective advantage over Merck's Welireg, analysts mention

.Along with brand new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ...

Roche bets as much as $1B to broaden Dyno genetics therapy shipping treaty

.After creating a gene treatment partnership with Dyno Therapeutics in 2020, Roche is actually back ...